IMPT-514
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IMPT-514, covering 2025-02-10 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy [EARLY_Phase 1]